reported that APS can downregulate the expression of interleukin (IL)-6/10, markedly increase the M1/M2 macrophage polarization ratio, contribute to the functional maturity of DC, enhance T cell-medicated anti-tumoral immune responses, improve the accuracy of tumor cell killing, and inhibit the growth of tumor cells (143). The gene discussed is IL6; the disease is neoplasm.